Drugs / Diphtheria, pertussis, and tetanus booster vaccine
Diphtheria, pertussis, and tetanus booster vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05543642 Comparator | Oct 2022 → Apr 2025 overdue | rheumatic disorder | Oregon Health and Science University | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphtheria, pertussis, and tetanus booster vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05543642 ↗ |
| Modality | Vaccine | “Diphtheria, pertussis, and tetanus booster vaccine” NCT05543642 ↗ |